An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 11, 2013, Pages 1625-1631

  Marsh, Rebecca A ^a   Kim, Mi Ok ^a   Liu, Chunyan ^a   Bellman, Denise ^a   Hart, Laura ^a   Grimley, Michael ^a   Kumar, Ashish ^a   Jodele, Sonata ^a   Myers, Kasiani C ^a   Chandra, Sharat ^a   Leemhuis, Tom ^a   Mehta, Parinda A ^a   Bleesing, Jack J ^a   Davies, Stella M ^a   Jordan, Michael B ^a   Filipovich, Alexandra H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Alemtuzumab; Bone marrow transplantation; Familial hemophagocytic lymphohistiocytosis; Hematopoietic cell transplantation; Hemophagocytic lymphohistiocytosis; Reduced intensity conditioning; SAP deficiency; X linked lymphoproliferative disease; XIAP deficiency

Indexed keywords

ALEMTUZUMAB; FLUDARABINE; MELPHALAN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE RESPIRATORY FAILURE; ADOLESCENT; ADULT; ARTICLE; CHILD; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; DONOR LYMPHOCYTE INFUSION; DRUG DOSE REGIMEN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; INFANT; INFECTIOUS COMPLICATION; MULTIPLE ORGAN FAILURE; PNEUMONIA; PRESCHOOL CHILD; REDUCED INTENSITY CONDITIONING; RESPIRATORY DISTRESS SYNDROME; SCHOOL CHILD; SEPSIS;

ALEMTUZUMAB; BONE MARROW TRANSPLANTATION; FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEMATOPOIETIC CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; REDUCED-INTENSITY CONDITIONING; SAP DEFICIENCY; X-LINKED LYMPHOPROLIFERATIVE DISEASE; XIAP DEFICIENCY;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84885730018     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.09.001     Document Type: Article

References (26)

1. Shenoy S., Grossman W.J., DiPersio J., et al. Anovel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 2005, 35:345-352.
2. Rao K., Amrolia P.J., Jones A., et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005, 105:879-885.
3. Satwani P., Cooper N., Rao K., et al. Reduced-intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases. Bone Marrow Transplant 2008, 41:173-182.
4. Ohga S., Kudo K., Ishii E., et al. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer 2010, 54:299-306.
5. Yoon H.S., Im H.J., Moon H.N., et al. The outcome of hematopoietic stem cell transplantation in Korean children with hemophagocytic lymphohistiocytosis. Pediatr Transplant 2010, 14:735-740.
6. Cesaro S., Locatelli F., Lanino E., et al. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP). Haematologica 2008, 93:1694-1701.
7. Baker K.S., Filipovich A.H., Gross T.G., et al. Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis. Bone Marrow Transplant 2008, 42:175-180.
8. Ouachee-Chardin M., Elie C., de Saint Basile G., et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics 2006, 117:e743-e750.
9. Horne A., Janka G., Maarten Egeler R., et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005, 129:622-630.
10. Cooper N., Rao K., Goulden N., et al. The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone Marrow Transplant 2008, 42(Suppl 2):S47-S50.
11. Marsh R.A., Vaughn G., Kim M.O., et al. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood 2010, 116:5824-5831.
12. Henter J.I., Samuelsson-Horne A., Arico M., et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002, 100:2367-2373.
13. Morris E.C., Rebello P., Thomson K.J., et al. Pharmacokinetics of alemtuzumab used for invivo and invitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications. Blood 2003, 102:404-406.
14. Rebello P., Cwynarski K., Varughese M., et al. Pharmacokinetics of CAMPATH-1H in BMT patients. Cytotherapy 2001, 3:261-267.
15. Shore T., Harpel J., Schuster M.W., et al. Astudy of a reduced-intensity conditioning regimen followed by allogeneic stem cell transplantation for patients with hematologic malignancies using Campath-1H as part of a graft-versus-host disease strategy. Biol Blood Marrow Transplant 2006, 12:868-875.
16. Dodero A., Carrabba M., Milani R., et al. Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed. Exp Hematol 2005, 33:920-927.
17. Chakraverty R., Orti G., Roughton M., et al. Impact of invivo alemtuzumab dose before reduced-intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution. Blood 2010, 116:3080-3088.
18. Cooper N., Rao K., Gilmour K., et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood 2006, 107:1233-1236.
19. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
20. Kruskal W.H., Wallis W.A. Use of ranks in one-criterion variance analysis. JAm Stat Assoc 1952, 47:583-621.
21. Fisher R.A. Statistical methods for research workers 1954, Oliver & Boyd, Edinburgh, UK.
22. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966, 50:163-170.
23. Peto R., Peto J. Asymptotically efficient rank invariant test procedures. JR Stat Soc A 1972, 135:185-207.
24. Kaplan E., Meier P. Nonparametric estimation from incomplete observations. JAm Stat Assoc 1958, 53:457-481.
25. Cox D. Regression models and life tables (with discussion). JR Stat SocB 1972, 34:187-220.
26. Klein J.P., Moeschberger M.L. Survival analysis: techniques for censored and truncated data 2010, Springer-Verlag, New York.